Hypofractionnement en radiothérapie : le retour ?
- 30 November 2005
- journal article
- review article
- Published by Elsevier BV in Cancer/Radiothérapie
- Vol. 9 (6-7), 366-373
- https://doi.org/10.1016/j.canrad.2005.09.013
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicityInternational Journal of Radiation Oncology*Biology*Physics, 2004
- New data on the value of α/β—evidence mounts that it is lowInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapyRadiotherapy and Oncology, 2004
- Human hormone-refractory prostate cancers can harbor mutations in the O 2 -dependent degradation domain of hypoxia inducible factor-1α (HIF-1α)Zeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissueInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional RadiationThe New England Journal of Medicine, 2001
- Fractionation and protraction for radiotherapy of prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: Emphasis on the role of exploratory laparotomy and fractionationRadiotherapy and Oncology, 1988
- Late Toxicity of Radiotherapy in Hodgkin's Disease—The Role of Fraction SizeActa Oncologica, 1988
- Accelerated treatmentCancer, 1985